DFX Intelligence

Allocator Intelligence

The capital-owner graph behind private markets. Who owns the capital, who decides, how much, under what policy, on whose advice, to which managers, and what changed, with a source and a date behind every row. A target is never an actual, a disclosed holding is never an approval, and an estimate says so.

Corporate pension

Irving Tissue Pension Plan

Corporate pensionFort Edward, NY
Assets
$24.1M
Total assets, Dec 31, 2024 reported
Funded
86.2%
Jan 1, 2024
Private markets target
n/a
policy Dec 31, 2024
Commitments
1
none on the tape
Plan sponsor: Irving Consumer Products, Inc.
Allocation policy
Form 5500, as of Dec 31, 2024
Actual allocation lines without a target (as filed)
  • Interest-bearing cash 1.4%
  • Registered investment companies 94.3%
Consultants and advisers
3 firms
People
No investment staff or executives have been read for this allocator yet.
Manager roster
1 managers on the commitment tape
From the plan’s own commitment disclosures
Commitments
1 rows, 0 dated closings
Disclosed holdings (from the plan’s performance or holdings report, as of the report date)
DateFundManagerBucketAmountVintageStatusSource
as of Dec 31, 2022Futurefunds Series Account IIseparate accountEmpower Annuity Insurance CompanyPooled vehicles$18.5M heldDisclosed holdingaskebsa.dol.gov
Size and funding
30 readings
Total assets
$24.1M Dec 31, 2024 reported Form 5500
$21.7M (2023-12) · $18.7M (2022-12)
Plan assets
$21.6M Jan 1, 2024 reported Form 5500
$18.7M (2023-01) · $22.8M (2022-01)
Net assets
$24.1M Dec 31, 2024 reported Form 5500
$21.7M (2023-12) · $18.7M (2022-12)
Funded ratio
86.2% Jan 1, 2024 reported Form 5500
84.4% (2023-01) · 95.3% (2022-01)
Funding target
$25.4M Jan 1, 2024 reported Form 5500
$24.4M (2023-01) · $23.0M (2022-01)
Discount rate
5.21% Jan 1, 2024 reported Form 5500
5.30% (2023-01) · 5.47% (2022-01)
Participants
225 Jan 1, 2024 reported Form 5500
226 (2023-01) · 226 (2022-01)
Contributions
$1.5M Dec 31, 2024 reported Form 5500
$822,527 (2023-12) · $538,509 (2022-12)
Benefits paid
$981,831 Dec 31, 2024 reported Form 5500
$1.0M (2023-12) · $971,693 (2022-12)
Net investment income
$2.4M Dec 31, 2024 reported Form 5500
$2.9M (2023-12) · $-4.1M (2022-12)
Form 5500 filings
3 plan years
Plan yearParticipantsAssets (SB market)Funding targetFTAPTotal assets (H)Partnerships / JVMaster trustReal estate
2024 to Dec 31, 2024225$21.6M$25.4M86.2%$24.1Mn/an/an/a
2023 to Dec 31, 2023226$18.7M$24.4M84.4%$21.7Mn/an/an/a
2022 to Dec 31, 2022226$22.8M$23.0M95.3%$18.7Mn/an/an/a
Service providers and investment entities as filed (Schedule C and D, latest year first)
What changed
5 events
  • Dec 31, 2024Assets changed
    Irving Tissue Pension Plan total assets $22M -> $24M (+11.1%, 2023-12-31 to 2024-12-31)
  • Jan 1, 2024Assets changed
    Irving Tissue Pension Plan plan assets $19M -> $22M (+15.7%, 2023-01-01 to 2024-01-01)
  • Dec 31, 2023Assets changed
    Irving Tissue Pension Plan total assets $19M -> $22M (+15.8%, 2022-12-31 to 2023-12-31)
  • Jan 1, 2023Funded status changed
    Irving Tissue Pension Plan funded ratio 95.3% -> 84.4% (2022-01-01 to 2023-01-01)
  • Jan 1, 2023Assets changed
    Irving Tissue Pension Plan plan assets $23M -> $19M (-18.1%, 2022-01-01 to 2023-01-01)
Board record: approvals, recommendations, searches, terminations and re-up prospects for this system.
Provenance
Identifiers: EIN-PN 043212875-003
Cross-graph: no entry on another DFX graph
First observed Sep 15, 2026, last observed Sep 15, 2026. Classification confirmed. Every row above carries its source; a reported figure is the subject’s own, a derived one is arithmetic on reported figures, an estimated one is a model or a survey imputation and is never summed into a headline.